ENT.AXENT.AXASX
Loading
| Metric | Q2 2023 | Q4 2023 | Q2 2024 | Q4 2024 | Q2 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +26.36% | +28.90% | +32.53% | +33.42% | +64.79% |
| Weighted Average Shares Diluted Growth | +26.36% | +28.82% | +32.53% | +33.42% | +64.72% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -36.14% | -53.66% | -48.35% | +2.68% | -10.67% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -22.80% | -20.95% | -23.72% | -18.14% | -12.45% |
| Book Value per Share Growth | -40.86% | -38.94% | -47.10% | -38.70% | -55.08% |
| Debt Growth | -78.07% | -90.10% | +72.88% | +130.63% | +179.10% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -60.44% | -57.46% | -64.33% | -1.84% | -35.27% |